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ORIGINAL ARTICLE

Spectrum of Histopathological Findings
in Postmenopausal Bleeding

ABSTRACT

Muhammad Usman Tariq, Romana Idrees, Ahmed Raheem and Naila Kayani

Objective: To determine the frequencies of histopathological findings in endometrial and endocervical biopsy samples
with clinical history of Postmenopausal Bleeding (PMB).
Study Design: Descriptive cross-sectional study.
Place and Duration of Study: Section of Histopathology, Department of Pathology and Laboratory Medicine, The Aga
Khan University Hospital, Karachi, from February 2012 to January 2013.
Methodology: A total of 157 consecutive endometrial and endocervical biopsy specimens with history of postmenopausal
bleeding were included. After microscopic examination, frequencies of histological findings in different age groups were
generated. Chi-square and independent sample t-tests were applied to see whether the difference was significant which
was set at p < 0.05.
Results: One hundred and twenty-one (77.1%) specimens showed benign pathologies while 36 (22.9%) were malignant.
Endometrial polyp was seen in 67 (42.7%) cases followed by endometrial carcinomas in 25 (15.9%), endometrial
hyperplasia in 21 (13.4%), cervical carcinoma in 12 (7.6%) and cervical polyps in 9 (5.7%) cases. A highly significant
increase in the percentage of malignant and pre-malignant lesions was seen with increasing age group (p < 0.001). Mean
age of patients with type-2 endometrial carcinoma was higher than type-1 endometrial carcinoma but statistical
significance was not observed (70.2 ±6.5 vs. 61.8 ±9.1 years respectively, p=0.069).
Conclusion: Although benign pathologies were more common in postmenopausal bleeding but the collective proportion
of endometrial and cervical malignancies and pre-malignant conditions was quite high. Therefore, PMB should be urgently
evaluated for cause and early commencement of treatment.
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INTRODUCTION

Postmenopausal Bleeding (PMB) is defined as “bleeding
through female genital tract, 12 months after the
cessation of menstrual cycles (menopause)”.1 It is a
manifestation of diverse diseases, accounting for
5 - 10% of the gynecology clinic visits.2 Postmenopausal
bleeding occurs over a wide age range and can result
from a number of pathologies arising in any of the
female genital tract organs, particularly uterus and
cervix.3 PMB can result from the normal physiologic
atrophic changes, infections, benign lesions such as
polyps, hyperplastic (pre-malignant) conditions and
aggressive malignant conditions. A number of systemic
disorders, especially blood dyscrasias are also
associated with this symptom.4
The incidence of malignancies in women with postmenopausal bleeding has varied over the period of time
and with study setting.5-13 Two of the studies conducted
in Pakistani setting by Dawood et al. and Jillani et al.
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have reported a higher incidence of malignancy in
comparison with the rest of the world.5,8

PMB is a warning symptom as it has significant
association with malignancies and it might be the only
and/or initial presenting symptom of these conditions.14-16
Dilatation and Curettage (D&C) is considered to be
a method of choice.17 Current guidelines mandate
immediate clinical evaluation and Trans-vaginal
Ultrasound (TVS) assessment followed by D&C or
hysteroscopy guided endometrial / endocervical biopsy
and subsequent histological evaluation.18

The incidence of carcinoma cervix has fallen
significantly in the developed countries due to regular
screening programs and subsequent detection at an
early level. Similarly, due to high public awareness about
the signs and symptoms of carcinoma endometrium,
women with PMB have early visit and detection at initial
stage.11,12 Because of lack of screening programs,
poverty, lack of health facilities and high illiteracy rate in
our country, this symptom is usually ignored along with
other medical problems and the women present at a
very late stage. Moreover, adoption of urban lifestyle has
led to an increase in obesity, hypertension and diabetes
mellitus in our population which are known risk factors
for endometrial cancer.16 Therefore, this threatening
medical situation necessitates the estimation of the
recent burden of these diseases.
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The aim of this study was to determine the frequencies
of different histopathological findings in specimens
received with a history of postmenopausal bleeding, at
histopathology section in a major referral centre in
Karachi, Pakistan.

METHODOLOGY

It was a prospective cross-sectional study conducted at
Section of Histopathology, Department of Pathology and
Microbiology, The Aga Khan University Hospital. The
study did not directly involve human subjects. Only the
results of diagnoses made on the biopsy material
submitted for histopathological examination were
analyzed and no additional intervention or test was
performed. Consecutive endometrial and endocervical
biopsy specimens with clinical history of PMB, received
over a period of one year, were included with lowest age
limit for inclusion being 32 years, being the lowest age of
menopause reported in Pakistan.3 Scanty biopsy
specimens and poorly fixed specimens were excluded.
The gross examination was performed according to the
guidelines by Rosai and Ackerman.19 Formalin-fixed,
paraffin embedded tissue sections were stained
with Haematoxylin & Eosin (H&E). The microscopic
examination was performed by two pathologists.
Variables including age and histopathological findings
were obtained on a pre-designed proforma.
Data was analyzed by using SPSS Version 19. Mean
value and standard deviation for age of women were
computed. Frequencies with percentages for outcome
variables including atrophic endometrium, endometrial
hyperplasia, endometrial carcinoma, carcinoma cervix,
polyps and other diagnosis were generated and
presented on pie charts. Cases were divided into four
age groups (≤ 50 years, 51 - 60 years, 61 - 70 years and
≥ 71 years). Cross tabulation was done with age groups
and types of histopathological findings and chi-square
test was applied to see the distribution of these findings
according to age. With 95% confidence interval and 5%
level of significance, p-value of < 0.05 was considered
significant. Independent sample t-test was applied to
compare the mean age of patient with type-1 and type-2
endometrial carcinoma. With 95% confidence interval,
5% level of significance (p-value < 0.05) was considered
significant.

common finding which was seen in 25 (15.9%) cases,
endometrial hyperplasia in 21 (13.4%) cases, carcinoma
cervix in 12 (7.6%) cases, cervical polyps in 9 (5.7%)
cases and atrophic endometrium in a single (0.6%)
case. Other, less common histopathological findings
comprised of 22 (14%) cases and included 6 (3.8%)
cases of glandular and stromal breakdown, 4 (2.5%)
cases of disordered proliferative pattern, 2 (1.3%) cases
of progesterone effect, 2 (1.3%) cases of anovulatory
cycle change, 2 (1.3%) cases of endometritis and a
single case, each of cervical dysplasia, cervical leiomyoma, cervical ulcer, proliferative endometrium,
excessive estrogen effect and non-secretory endometrium.
Among the endometrial biopsies, polyps comprised
50.3% (Figure 1). Among cervical biopsies, carcinomas
comprised the majority, i.e. 50%, polyps (Figure 2).

In the 21 cases of endometrial hyperplasia, 10 (47.6%)
cases were simple hyperplasia without atypia, 9 (42.8%)
were complex hyperplasia with atypia and 2 (9.5%) were
complex hyperplasia without atypia. Simple hyperplasia
with atypia was not seen in any case.

In the 25 endometrial carcinomas, 20 (80%) cases were
endometrioid carcinoma (type-1), 2 (8%) cases were
serous adenocarcinoma, 2 (8%) cases were clear cell
adenocarcinoma (type-2) and a single case was
Malignant Mixed Mullerian Tumor (MMMT). Among the
20 cases of endometrioid adenocarcinomas, 4 (20%)

Figure 1: Frequencies of histopathologic findings in endometrial biopsies.

RESULTS

Patients' age ranged from 38 - 80 years with a mean
value of 57.6 ±8.1 years. Most of the patients (45.2%)
were in the sixth decade.

Out of 157 samples, 133 (84.7%) were endometrial
biopsies and 24 (15.3%) were endocervical biopsies.
Overall, endometrial polyp was the most common
histopathological finding which was seen in 67 (42.7%)
cases. Carcinoma of endometrium was the second most

Figure 2: Frequencies of histopathologic findings in endocervical biopsies.
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Table I: Comparison of age-wise distribution of benign, pre-malignant
and malignant cases.
Benign

Pre-malignant and malignant

51 (71.8%)

20 (28.2%)

2 (18.2%)

9 (81.8%)

≤ 50 years

29 (87.9%)

61-70 years

28 (67.7%)

51-60 years
≥ 71 years

4 (12.1%)

p-value

p <0.001

14 (33.3%)

Table II: Proportion ages (in years) of type 1 and type 2 endometrial
carcinomas patients in different age groups.
Type-1 endometrial
carcinoma (n=20)
overall mean

≤ 50 years

51-60 years
61-70 years
≥71 years

(61.8 ± 9.1 years)
29 (87.9%)

Type-2 endometrial
carcinoma (n=5)
overall mean

(70.2 ± 6.5 years)
4 (12.1%)

51 (71.8%)

20 (28.2%)

2 (18.2%)

9 (81.8%)

28 (67.7%)

p-value

p = 0.069

14 (33.3%)

were FIGO grade I, 10 (50%) were FIGO grade-II and 6
(30%) were FIGO grade-III.
Among the 12 cases of carcinoma cervix, 6 (50%) were
well differentiated, 4 (37.5%) were moderately
differentiated and 2 (12.5%) were poorly differentiated.

These histopathologic findings were distributed in all
four age groups. Ten cases of pre-malignant lesions
(complex hyperplasia with atypia and cervical
dysplasia), 25 cases of carcinoma endometrium and 17
cases of carcinoma cervix were combined in a single
group of malignant and pre-malignant lesions. The
percentage of malignant and pre-malignant cases
increased with ascending age group. With 95%
confidence interval and 5% level of significance, Chisquare test was applied and a highly significant p-value
was observed (p < 0.001, Table I).
Mean ages of type-1 endometrial carcinoma (n=20) and
type-2 endometrial carcinoma (n=5) were 61.8 ±9.1 years
and 70.2 ±6.5 years, respectively (p=0.069, Table II).

DISCUSSION

Postmenopausal bleeding is one of the common
complaints which are encountered in the period
secondary to cessation of follicular activity.20 PMB not
only causes disturbance of the normal routine itself, but
it can also become related to additional morbidity due to
underlying gynecologic or systemic pathology. The
histologic evaluation of endometrium, after clinical and
TVS examinations, is mandatory according to recent
guidelines. Endometrial sampling is obtained by safe,
quick and an easy procedure performed in clinic
setting.18

Mean age of menopause in Pakistani population has
been reported to range from 32 to 62 years.3 The age
range of women with history of postmenopausal
bleeding in this study ranged from 38 to 80 years with
796

mean age of 57.1 ±8.1 years, which is comparable to the
other studies. Most of the studies conducted
internationally with a large dataset have included
endometrial as well as endocervical biopsy specimens.
However, few of the studies conducted in our country
had a small sample size and included endometrial
biopsies only and, therefore, ignored readily performed
endocervical biopsies which contribute a significant
percentage of pathologies responsible for PMB.11 In this
study, 24 endocervical biopsy specimens were included
which comprised 15.3% of the total specimens and
provided a good idea of the PMB causes of cervical
origin.

Benign pathology was observed in majority (70%) of the
cases. Endometrial Polyp (EP) was the most common
finding that was seen in 67 (42.8%) cases and this
incidence was much higher than that reported in the
literature as the incidence of EP in postmenopausal age
group has ranged from 2.03 to 12%.1,8 Removal of the
polyps and thorough histological examination become
important as these lesions have the rare ability to give
rise to pre-malignant and malignant conditions.21 Those
cases of study, which showed such transformation were
included in the malignant or pre-malignant category for
the sake of simplicity.
Endometrial Hyperplasia (EH) was observed in 21
(13.4%) cases which was in concordance and the
incidence reported in various national and international
studies (5 - 17%).5-10 The risk of malignant transformation increases with increase in complexity and
atypia from 1 to 29% and, therefore, sampling of such
lesion becomes mandatory in order to rule out
malignancy.22 Among different types of hyperplasia in
this study, complex hyperplasia with atypia and simple
hyperplasia without atypia constituted the major bulk i.e.
47.6% and 42.8% cases respectively.

Endometrial Carcinoma (EC) is the third most common
malignancy of females in Pakistan with peak incidence
in sixth and seventh decades.22 The incidence of EC has
ranged from 4.8 to 22.5% in different studies conducted
in the local setting.5-10 In a recent international study
conducted in postmenopausal women, Burbos et al.
reported a lower incidence (5%) of endometrial
carcinoma.7 EC comprised 15.9% of the present
reported histological findings. Out of these 25 cases, 20
(80%) were type-1 and 5 (20%) were type-2. Out of
these type-2 lesions, two were serous adenocarcinoma,
two were clear cell adenocarcinoma and 01 was
Malignant Mixed Mullerian Tumor (MMMT). Majority of
the endometrioid (type-1) endometrial EC were of FIGO
grade-II. The percentage of EC is similar to the
incidence reported earlier in the country. However, we
think that the failure to reduce the malignancy rate, as
achieved in the western countries, can be attributed to
high illiteracy rate, lack of health facilities, delay in
seeking medical advice and an increase in the risk
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factors for EH, such as hypertension and diabetes
mellitus.23 The mean age of type-1 EC (61.8 ±9.1 years)
was lower than the mean age of type-2 EC (70.2 ±6.5
years) which is in concordance with the reported
literature.24 But statistical significance was not observed,
probably because of small number of cases in each
cohort.

Carcinoma of cervix is the third most common malignant
cause of mortality in females. The incidence has
decreased over the past few decades in western
countries.25 In Pakistan, the incidence of carcinoma
cervix ranges from 2.5 to 25.5%.5-11 Carcinoma of cervix
was observed in 7.6% of these cases and apart from
these 12 cases, a single case of cervical dysplasia was
also observed. All over the world, the peak incidence is
seen in 5th decade but the peak incidence in this study
was seen in sixth and seventh decades which also
points to the late presentation due to poverty and
unawareness.

Atrophic endometrium has been the most common
cause of PMB worldwide but we surprisingly noted a
single case with atrophic endometrium.1,2,6,7 In the
authors’ opinion, the increased use of estrogen to avoid
the other estrogen withdrawal symptoms in the
postmenopausal period may have prevented the
atrophic process.

CONCLUSION

A variety of histopathological findings are seen in PMB.
Although benign pathologies were more common but the
collective proportion of endometrial and cervical
malignancies and pre-malignant conditions is considerably
higher in this study. The clinicians should educate the
patients about the alarming symptom of PMB and
emphasize the need for seeking urgent medical advice
and early commencement of treatment.
Disclosure: This is a dissertation based article.
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